Trial Profile
The Role of Leptin Levels in Multiple Sclerosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 15 Jun 2012 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
- 15 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Feb 2010 New trial record